Department of Orthopaedic One, Xi'an Gaoxin Hospital, No. 16, South Tuanjie Road, Xi'an, 710075, China,
Biotechnol Lett. 2013 Oct;35(10):1645-53. doi: 10.1007/s10529-013-1248-9. Epub 2013 Jun 21.
A double-chamber bioreactor has been developed to generate a tissue-engineered osteochondral composite (TEOC). However, a TEOC generally requires two types of cells (i.e. chondrogenic and osteogenic cells). Therefore, the capacity of mesenchymal stem cells (MSCs) as a single-cell source to work within a double-chamber bioreactor and biphasic scaffolds for generating TEOC was investigated. Compared with static culture, the double-chamber bioreactor not only can promote faster cellular proliferation, indicated by the PicoGreen dsDNA assay, SEM and confocal imaging, but also can trigger efficient chondrogenic and osteogenic differentiation of MSCs in biphasic scaffolds simultaneously, evidenced by gene expression. Thus MSCs are promising as the ideal single-cell source and the double-chamber bioreactor is an advanced culture system to generate TEOC.
已经开发出一种双室生物反应器来生成组织工程化的骨软骨复合材料(TEOC)。然而,TEOC 通常需要两种类型的细胞(即软骨细胞和成骨细胞)。因此,研究了间充质干细胞(MSCs)作为单细胞来源在双室生物反应器和双相支架内工作以生成 TEOC 的能力。与静态培养相比,双室生物反应器不仅可以通过 PicoGreen dsDNA 测定法、SEM 和共聚焦成像来促进更快的细胞增殖,而且还可以同时在双相支架中触发 MSC 的有效软骨和成骨分化,这可以通过基因表达来证明。因此,MSCs 有望成为理想的单细胞来源,而双室生物反应器是生成 TEOC 的先进培养系统。